Parstatin (mouse) is a peptide derived from the proteinase-activated receptor 1 (PAR1). It is primarily studied for its role in modulating inflammation and angiogenesis, making it a potential candidate for therapeutic applications in conditions involving these processes. Research has shown that Parstatin can inhibit the formation of new blood vessels (angiogenesis), which is crucial in cancer and tumor growth. Additionally, it has anti-inflammatory properties and can prevent cell death (apoptosis) in injured tissues, suggesting potential uses in managing inflammatory disorders such as arthritis, cardiovascular diseases, and wound healing. Ongoing research focuses on its efficacy, mechanisms, and development as targeted therapies.